trial · primary record
TAK-505
Malignant Solid Tumors
| Phase | Phase 1, Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 151 |
| Primary completion | 2030-08-18 |
| Primary endpoint | Phase 1 Dose Escalation: Number of Participants With Dose Limiting Toxicities (DLTs) |
| Registry ID | NCT07436728 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T13:38:58.703Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07436728
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.